Hereditary prostate cancer: Clinical aspects

Journal of Urology

Volumn 168, Issue 3, 2002, Pages 906-913

  Bratt, Ola ^a  

^a HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Genetic markers; Hereditary; Neoplastic syndromes; Prostate; Prostatic neoplasms

Indexed keywords

CANCER MORTALITY; CANCER RISK; CANCER SCREENING; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; GENE MAPPING; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; MALE; MEDLINE; ONCOGENE; ONSET AGE; PENETRANCE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0036717993     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)64541-7     Document Type: Review

References (104)

1. Recherches clinico-statistiques et genetiques sur les neoplasies de la prostate
2. Mendelian inheritance of familial prostate cancer
3. Major susceptibility locus for prostate cancer on chromosome I suggested by a genome-wide search
4. Predisposing gene for early-onset prostate cancer, located on chromosome 1q42.2-43
5. Evidence for a rare prostate cancer susceptibility locus at chromosome 1p36
6. Evidence for a prostate cancer susceptibility locus on the X chromosome
7. Evidence for a prostate cancer-susceptibility locus on chromosome 20
8. A candidate prostate cancer susceptibility gene at chromosome 17p
9. Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4
10. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus
11. Linkage and association studies of prostate cancer susceptibility: Evidence for linkage at 8p22-23
12. Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark, and Finland
13. Hereditary prostate cancer
14. Age specific risks of familial prostate carcinoma: A basis for screening recommendations in high risk populations
15. Detection of subclinical cancers by prostate-specific antigen screening in asymptomatic men from high-risk families
16. Evidence of an X-linked or recessive genetic component to prostate cancer risk
17. The impact of family history on early detection of prostate cancer
18. Family history and prostate cancer risk
19. Family history and prostate cancer risk in a population-based cohort of Iowa men
20. Evidence for autosomal dominant inheritance of prostate cancer
21. A genetic epidemiological study of hereditary prostate cancer (HPC) in Finland: Frequent HPCX linkage in families with late onset disease
22. Segregation analyses of 1,476 population-based Australian families affected by prostate cancer
23. Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families
24. Family history and the risk of prostatic carcinoma in a high risk group of urological patients
25. Estimation of prostate cancer probability by logistic regression: Free and total prostate-specific antigen, digital rectal examination, and heredity are significant variables
26. Hereditary prostate cancer: Epidemiologic and clinical features
27. Familial aspects of prostate cancer: A case control study
28. Familial and hereditary prostate cancer in southern Sweden. A population-based case-control study
29. Prostate cancer susceptibility locus on chromosome lq: A confirmatory study
30. Re: Prostate cancer susceptibility locus on chromosome lq: A confirmatory study
31. Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees
32. Cancer risk in families with hereditary prostate cancer
33. Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics
34. Linkage analysis at the chromosome 1 loci 1q24-25 (HPC1), 1q42.2-43 (PCAP), and 1p36 (CAPB) in families with hereditary prostate cancer
35. Linkage of prostate cancer susceptibility loci to chromosome 1
36. Linkage analysis of 49 highrisk families does not support a common familial prostate cancer-susceptibility gene at 1q24-25
37. Linkage analysis of chromosome 1Q markers in 136 prostate cancer families
38. A genomic scan of families with prostate cancer identifies multiple regions of interest
39. A genome screen of multiplex sibships with prostate cancer
40. Analysis of HPC1, HPCX, and PCaP in Icelandic hereditary prostate cancer
41. PCAP is the major known prostate cancer predisposing locus in families from south and west Europe
42. A genome screen of families with multiple cases of prostate cancer: Evidence of genetic heterogeneity
43. Low frequency of allelic imbalance at the prostate cancer susceptibility loci HPC1 and 1p36 in Swedish men with hereditary prostate cancer
44. Allelic imbalance in familial and sporadic prostate cancer at the putative human prostate cancer susceptibility locus, HPC1. CRC/BPG UK Familial Prostate Cancer Study Collaborators
45. Infrequent allelic imbalance at the major susceptibility HPC1 locus in sporadic prostate tumours
46. Loss of heterozygosity and microsatellite instability at chromosomal sites 1Q and 10Q in morphologically distinct regions of late stage prostate lesions
47. Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer
48. Genetic linkage of prostate cancer families to Xq27-28
49. Linkage analysis of 153 prostate cancer families over a 30-cM region containing the putative susceptibility locus HPCX
50. Mutation and cancer: Statistical study of retinoblastoma
51. Suggestive evidence for a site specific cancer gene on chromosome 1p36
52. Association of HPC2/ELAC2 genotypes and prostate cancer
53. Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls
54. HPC2 variants and screen-detected prostate cancer
55. Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer
56. ELAC/HPC2 involvement in hereditary and sporadic prostate cancer
57. Evidence for a prostate cancer linkage to chromosome 20 in 159 hereditary prostate cancer families
58. Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancer
59. No evidence of linkage to HPC20 (on chromosome 20q13) in hereditary prostate cancer
60. Genetics of prostate cancer: Too many loci, too few genes
61. Androgen metabolism and prostate cancer: Establishing a model of genetic susceptibility
62. Prostate cancer associated with CYP17 genotype
63. Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways
64. Risk of cancer in relatives of prostate cancer probands
65. Relatives of prostate cancer patients have an increased risk of prostate and stomach cancers; a population-based, cancer registry study in Finland
66. Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives
67. BRCA1 and prostate cancer
68. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium
69. Cancer risk in BRCA2 mutation carriers
70. Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers
71. BRCA2 mutation in Icelandic prostate cancer patients
72. BRCA2 mutation in a family with hereditary prostate cancer
73. BRCA1 and BRCA2 have a limited role in familial prostate cancer
74. Pathological features of hereditary prostate cancer
75. Early-onset prostate cancer is not associated with specific clinical features
76. Hereditary prostate cancer: Clinical characteristics and survival
77. Clinical and pathological features of hereditary prostate cancer
78. Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy
79. Patterns of inheritance and outcome in patients treated with external beam radiation for prostate cancer
80. Familial prostate cancer: Outcome following radiation therapy with or without adjuvant androgen ablation
81. Biological aggressiveness of hereditary prostate cancer: Long-term evaluation following radical prostatectomy
82. No difference in survival between sporadic, familial and hereditary prostate cancer
83. Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus
84. Familial prostate cancer: A different disease?
85. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer
86. Psychological distress and surveillance behaviors of women with a family history of breast cancer
87. Efficacy of screening mammography. A meta-analysis
88. The European Randomized Study of Screening for Prostate Cancer (ERSPC)
89. National trends in the epidemiology of prostate cancer, 1973 to 1994: Evidence for the effectiveness of prostate-specific antigen screening
90. American Cancer Society guidelines for the early detection of prostate cancer: Update, June 10, 1997
91. Serum concentrations of prostate specific antigen and its complex with alfa 1-antichymotrypsin before diagnosis of prostate cancer
92. Evaluation of the digital rectal examination as a screening test for prostate cancer. Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
93. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium
94. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer
95. Cancer risk notification: Psychosocial and ethical implications
96. Genetic information and the workplace: Legislative approaches and policy challenges
97. What you don't know can hurt you: Adverse psychologic effects in members of BRCA1-linked and BRCA2-linked families who decline genetic testing
98. Psychosocial impact of testing (by linkage) for the BRCA1 breast cancer gene: An investigation of two families in the research setting
99. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. Adopted on February 20, 1996
100. Sons of men with prostate cancer: Their attitudes regarding possible inheritance of prostate cancer, screening, and genetic testing
101. Men's attitudes genetic testing for hereditary prostate cancer risk
102. Germline mutations in the ribonuclease L gene in families showing linkage with HPC1